ClinicalTrials.Veeva

Menu

Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS

Biogen logo

Biogen

Status

Completed

Conditions

Multiple Sclerosis

Study type

Observational

Funder types

Industry

Identifiers

NCT04145284
888MS007

Details and patient eligibility

About

The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).

Enrollment

6 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • Board-certified neuroradiologists or experienced neuroradiology fellows.
  • Employed at a participating MS PATHS institution.
  • At least 3 years of experience in interpreting brain MRI scans of MS participants.

Key Exclusion Criteria:

  • Inability to comply with sub-study procedures.
  • Other unspecified reasons that, in the opinion of Biogen or the MS PATHS Radiology Lead at the institution, make the radiologist unsuitable for participation.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems